. Prospective studies of 3.75 years in 4000 children <3 years old indicate primary HHV-6 illness causes a sizable healthcare burden, resulting in 20% of emergency room (ER) visits for acute illness in 6-12 month olds and one-third of febrile seizures in <2 years old evaluated in the ER. Association of HHV-6 with complicated adult disease suggests HHV-6 may result in further healthcare costs at the other end of the age spectrum. The application posits that the link spanning the age spectrum is the persistence and reactivation of HHV-6 in the interval years. The three Specific Aims are to determine: 1) whether HHV-6 persists for years in normal children, whether it reactivates, and whether risk factors are identifiable; 2) if HHV-6 is transmitted congenitally; and 3) the nature of the neurotropism of HHV-6, its pathologic and neurologic outcomes.
For Aim 1, the plan is to follow 200 previously-studied children for 5 years, at which time they will be 7-12 years old, to delineate the clinical and virologic course of persistent HHV-6 and risk factors such as age, characteristics of initial infection, sites, variants, and concurrent illness. These will be correlated to the viral replicative state. Clinical assessment will involve the interviews of parents and physician, diary cards, record reviews, routine and illness visits with blood and saliva samples. Reactivation will be assessed when the child is healthy and ill by serology, detection of persistent HHV-6 by variant-specific polymerase chain reactions (PCR) and the replicative state by reverse transcriptase PCR (RT-PCR).
Aim 2 will be studied in 200 normal newborns (half with and half without HHV-6 DNA in their cord blood). They will be followed up to the time of primary infection to determine the mode of transmission of asymptomatic neonatal infection and the clinical and immune effect on subsequent HHV-6 infection. The mode of transmission and later active infection will be assessed by serology, PCR, viral isolation, and RT-PCR. HHV-6 neurotropism (Aim 3) will be examined in vitro by studies of HHV-6 infection in central nervous system (CNS) tissue and clinically by the outcome measures of recurrent seizures and neurologic development. 690 children examined in the ER with their first febrile seizure (90 with seizures from HHV-6) will be followed for 2 years for recurrent seizures. A matched subgroup of 180 (90 with seizures from HHV-6 and 90 with seizures not from HHV-6) will be compared for neurologic development after 3 years by neurologic examinations and standardized neuropsychologic testing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033020-06
Application #
2672144
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1992-07-01
Project End
2002-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Rochester
Department
Pediatrics
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Caserta, Mary T; Hall, Caroline Breese; Schnabel, Kenneth et al. (2010) Diagnostic assays for active infection with human herpesvirus 6 (HHV-6). J Clin Virol 48:55-7
Caserta, Mary T; Hall, Caroline Breese; Schnabel, Ken et al. (2007) Human herpesvirus (HHV)-6 and HHV-7 infections in pregnant women. J Infect Dis 196:1296-303
Hall, Caroline Breese; Caserta, Mary T; Schnabel, Kenneth C et al. (2006) Characteristics and acquisition of human herpesvirus (HHV) 7 infections in relation to infection with HHV-6. J Infect Dis 193:1063-9
Caserta, Mary T; McDermott, Michael P; Dewhurst, Stephen et al. (2004) Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J Pediatr 145:478-84
Hall, Caroline Breese; Caserta, Mary T; Schnabel, Kenneth C et al. (2004) Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 145:472-7
Caserta, M T; Mock, D J; Dewhurst, S (2001) Human herpesvirus 6. Clin Infect Dis 33:829-33
Norton, R A; Caserta, M T; Hall, C B et al. (1999) Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol 37:3672-5
Lanphear, B P; Hall, C B; Black, J et al. (1998) Risk factors for the early acquisition of human herpesvirus 6 and human herpesvirus 7 infections in children. Pediatr Infect Dis J 17:792-5
Saito, Y; Sharer, L R; Dewhurst, S et al. (1995) Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol 1:30-9
Thomson, B J; Dewhurst, S; Gray, D (1994) Structure and heterogeneity of the a sequences of human herpesvirus 6 strain variants U1102 and Z29 and identification of human telomeric repeat sequences at the genomic termini. J Virol 68:3007-14

Showing the most recent 10 out of 13 publications